Day: August 12, 2020

TORONTO, Aug. 12, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits. These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes.The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.View...

Attacks Target Organizations With Remote Operations and Vulnerable RDPs“Have fun, bro!”: Dharma’s Entry-Level Color by Numbers Ransomware Toolkit Thrives Alongside  Advanced Multi-Million Dollar Ransomware AttacksOXFORD,  United Kingdom, Aug. 12, 2020 (GLOBE NEWSWIRE) — Sophos, a global leader in next-generation cybersecurity, today published, “Color by Numbers: Inside a Dharma Ransomware-as-a-Service (RaaS) Attack,” which provides the first in-depth look at an automated attack script and toolset created by the ransomware operators and provided to cybercriminal buyers together with back-end infrastructure and malicious tools. The report also shows how Dharma is targeting small and mid-sized businesses (SMBs) in 2020.Dharma has been known since 2016, and is one of the most profitable ransomware families around, due to its mass-market,...

PLEASANTON, Calif. and ARMONK, N.Y., Aug. 12, 2020 (GLOBE NEWSWIRE) — Workday (NASDAQ: WDAY) and IBM (NYSE: IBM) today announced an expanded partnership and the availability of a joint solution to help business and community leaders plan, schedule, and monitor a safe return to the workplace for employees.As organizations begin to address how to prioritize safety in bringing employees back to the workplace, they must consider a myriad of factors, including health, local guidelines, governmental policies, employee sentiment, facility readiness, and personal protective equipment (PPE). Every organization has a unique strategy that must be mapped to their specific facilities and workforce requirements. Together, IBM and Workday are delivering a solution to support and accelerate their customers’ return to the workplace by combining planning...

“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTIONTO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES”VANCOUVER, British Columbia, Aug. 12, 2020 (GLOBE NEWSWIRE) — Sonoro Metals Corp. (TSXV: SMO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed a non-brokered private placement for $8,000,000 with a lead order from Palisades Goldcorp Ltd.  The private placement was initially announced on July 23, 2020 for 22,727,273 Units and was increased, as announced on July 31, 2020, by way of an overallotment option of up to 60% (i.e. an additional 13,636,364 Units) at $0.22 per Unit, for total gross proceeds of $8,000,000 (collectively, the “Offering”).  Each Unit consists of one Sonoro Common Share and one Share Purchase Warrant.  Each warrant entitles...

Expands and files two USPTO provisional patent applications jointly with the Massachusetts Institute of Technology (MIT) Media Lab to develop a cytokine-specific blood purification system based on Avalon’s proprietary AVA-Trap™ technologyReflects advancements to Avalon’s AVA-Trap™ blood filtration system designed to rid the body of cytokines unleashed during the “cytokine storm” and acute respiratory distress syndrome (ARDS) in COVID-19 patients, as well as cancer patients treated with CAR T-cell therapy and other patients that require rapid removal of cytokines from the body The expanded patent application combines two novel technologies—S-layers and a protein design code tool—for a decoy cytokine receptor system to filter out pro-inflammatory cytokine levels in the blood in those experiencing cytokine stormFREEHOLD, N.J., Aug. 12, 2020...

LOUISVILLE, KY., Aug. 12, 2020 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) announced today an update to the detailed 62-page Kentucky Derby 146 Safety Plan released by Churchill Downs Racetrack (“Churchill Downs”). The Safety Plan applies to all live race days during this year’s rescheduled Kentucky Derby Week and will limit the attendance to less than 23,000 fans (less than 14% of the attendance record) for the 146th running of the Kentucky Derby on Saturday, September 5, 2020.   Attendance will be limited to guests with reserved seats with a maximum of 40% occupancy of reserved seats. All General Admission ticket options including the Infield are eliminated. Temperature checks, medical questionnaires, physical distancing and face coverings will be required upon entrance and movement within the 190-acre...

伊利诺伊州威尔梅特, Aug. 12, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc.（Nasdaq: MNPR）今天宣布了一种检测方法的开发计划，这种方法有可能按发展为重度呼吸系统衰竭的可能性来对新冠肺炎患者进行分流。这项检测将使用Monopar拥有专利的单克隆抗体ATN-658来探测新冠肺炎患者血浆中的可溶性尿激酶型纤溶酶原激活物受体 (suPAR)。这项针对新冠肺炎患者的suPAR检测如果成功，将能够识别出重度呼吸系统衰竭的高危患者，以便提早进行治疗干预，或者基于患者的疾病特征对其进行分期，以给予相应的最佳治疗。一种使用ATN-658进行血液suPAR测量的酶联免疫吸附检测 (ELISA) 原型现已开发完成，Monopar目前正在与多方进行讨论，以便对ELISA或其他使用ATN-658的suPAR检测方法做进一步开发或实现商业化。其目标是对基于suPAR的检测进行新冠肺炎患者中的临床验证。将suPAR用于新冠肺炎患者分流得到了越来越多近期研究的支持。Rovina等人2020年的文章表明，入院时suPAR水平较高的患者发展为重度呼吸系统衰竭的可能性要高出17倍 (p= 0.000000012) 。Arnold等人2020年的文章表明， 在所有接受考查的生物标志物中，suPAR在预测结局方面（如转入重症监护室和死亡）表现最佳；Eugen-Olsen等人2020年的文章表明，新冠肺炎患者suPAR水平较低预示轻症结局。“suPAR正在成为一种重要的生物标志物，能够预测新冠肺炎、某些肺炎和败血症等以急性和重度全身炎症反应为特征的多种疾病的结局。” Monopar首席科学官Andrew Mazar博士表示。“这种suPAR检测可能有助于及早识别病情会迅速恶化的患者，从而大大改善对新冠肺炎患者的治疗。”suPAR是细胞表面被称为尿激酶型纤溶酶原激活物受体 (uPAR) 的表面锚定蛋白切割、血液循环形式。Monopar最近与NorthStar...

MIAMI, Aug. 12, 2020 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today telehealth provider MDLink has partnered with MicroLabs to offer private PCR lab testing for COVID -19, as well as in-home phlebotomy and lab testing for other conditions. Prior to this agreement, only public testing options were available to the general public. MDLink is one of the first telemedicine providers to offer this PCR to its patients through the Microlabs partnership.Additionally, MDLink plans to go live with its COVID-19 screening tool developed through a technical cooperation agreement with the Inter-American Development Bank IDB Lab. This technical cooperation agreement was the subject of a July 21, 2020 press release....

Redesigned Blink Network for members and hosts improves user experience and is optimized for mobile usersMiami Beach, FL, Aug. 12, 2020 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner and operator of electric vehicle (EV) charging equipment and services, today announced significant changes to its membership program in conjunction with an improved network user experience and completely redesigned website.The Company has launched a completely redesigned navigation and visual look to its proprietary network portal, the Blink Network, and the BlinkCharging.com website.The updated Blink Network features all of the original member and host functionalities, including charger management, extensive reporting, role-based controls, and dynamic information securely available anytime from...